Overview

Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer

Status:
Terminated
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
Prevention and treatment of the severity of symptoms of chemotherapy-induced peripheral neuropathy.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin